Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AKTX

Akari Therapeutics

$2.09

0.055 (2.71%)

16:36
10/09/18
10/09
16:36
10/09/18
16:36
Syndicate
Akari Therapeutics files to sell 445M ordinary shares for holders »

Which represent 4.45M of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

$2.49

0.175 (7.56%)

12:13
09/30/18
09/30
12:13
09/30/18
12:13
Hot Stocks
Akari announces new data in post-transplant thrombotic microangiopathies »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

AKTX

Akari Therapeutics

$2.10

0.06 (2.94%)

07:08
09/27/18
09/27
07:08
09/27/18
07:08
Hot Stocks
Akari Therapeutics enters Securities Purchase Agreement with Aspire Capital »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

AKTX

Akari Therapeutics

$2.10

0.06 (2.94%)

06:58
09/27/18
09/27
06:58
09/27/18
06:58
Earnings
Breaking Earnings news story on Akari Therapeutics »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

Over a month ago
AKTX

Akari Therapeutics

$2.05

-0.05 (-2.38%)

07:21
09/12/18
09/12
07:21
09/12/18
07:21
Hot Stocks
Akari Therapeutics announces results from Coversin model »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

$1.83

-0.055 (-2.93%)

07:13
08/17/18
08/17
07:13
08/17/18
07:13
Earnings
Akari Therapeutics reports Q1 EPS 0c, two estimates (44c) »

As of March 31, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
AKTX

Akari Therapeutics

$1.88

-0.02 (-1.05%)

08:08
05/21/18
05/21
08:08
05/21/18
08:08
Hot Stocks
Akari Therapeutics receives Nasdaq notice related to delay in 20-F filing »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACER

Acer Therapeutics

$18.63

-0.28 (-1.48%)

, ACRS

Aclaris Therapeutics

$18.14

0.1 (0.55%)

07:10
05/03/18
05/03
07:10
05/03/18
07:10
Conference/Events
William Blair to hold a conference »

Late-Stage Therapeutics…

ACER

Acer Therapeutics

$18.63

-0.28 (-1.48%)

ACRS

Aclaris Therapeutics

$18.14

0.1 (0.55%)

AKTX

Akari Therapeutics

$2.08

0.09 (4.52%)

ALBO

Albireo Pharma

$29.81

-0.69 (-2.26%)

ANAB

AnaptysBio

$94.05

-2.09 (-2.17%)

ASMB

Assembly Biosciences

$45.00

0.39 (0.87%)

ATHX

Athersys

$2.05

0.03 (1.49%)

AVXS

AveXis

$216.73

0.18 (0.08%)

BHVN

Biohaven Pharmaceutical

$28.98

0.23 (0.80%)

CFRX

ContraFect

$1.55

0.05 (3.33%)

CMRX

Chimerix

$4.75

0.02 (0.42%)

FP

Firstplus Financial Group Inc

$0.00

(0.00%)

LOXO

Loxo Oncology

$126.10

0.11 (0.09%)

MRNS

Marinus Pharmaceuticals

$4.74

0.24 (5.33%)

NCNA

NuCana

$23.80

-0.32 (-1.33%)

NKTR

Nektar

$85.31

1.22 (1.45%)

ONCE

Spark Therapeutics

$74.07

-0.89 (-1.19%)

OVID

Ovid Therapeutics

$9.68

0.08 (0.83%)

PFNX

Pfenex

$5.50

-0.05 (-0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 07

    May

  • 08

    May

  • 08

    May

  • 08

    May

  • 08

    May

  • 10

    May

  • 20

    May

  • 21

    May

  • 21

    May

  • 12

    Jun

AKTX

Akari Therapeutics

$2.19

0.08 (3.79%)

05:13
02/08/18
02/08
05:13
02/08/18
05:13
Initiation
Akari Therapeutics initiated at B. Riley FBR »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

AKTX

Akari Therapeutics

$2.36

-0.18 (-7.09%)

07:06
02/06/18
02/06
07:06
02/06/18
07:06
Hot Stocks
Akari Therapeutics says Phase II COBALT Trial of Coversin met primary endpoint »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.